Abstract
An 8-year-old girl of African descent presented to the hospital with a headache, lethargy, pallor and ‘Coca-Cola’-coloured urine. She had been admitted 11 days before withPlasmodium falciparummalaria, which was successfully treated with 48 hours of parenteral artesunate. Investigations revealed signs of severe haemolytic anaemia, with a haemoglobin level of 52 g/L that reached a nadir of 10 g/L within 4 hours, in addition to haemoglobinuria, hyperbilirubinaemia and raised lactate dehydrogenase levels. She was diagnosed with post-artemisinin delayed haemolysis, which is usually self-limiting but has the potential to cause severe, life-threatening anaemia 7–21 days following malaria treatment with artesunate. There was excellent response to blood transfusion, and the child made a full recovery. This case highlights the importance of providing safety netting advice regarding signs and symptoms of anaemia to patients receiving artesunate, in addition to monitoring of haemoglobin levels in the weeks after treatment.
Reference24 articles.
1. Public Health England . Malaria imported into the United Kingdom. London: Public Health England, 2018. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/812824/Malaria_imported_into_the_United_Kingdom_2018.pdf
2. World Health Organization . Malaria. World Health organization, 2020. Available: https://www.who.int/news-room/fact-sheets/detail/malaria [Accessed 30 Jun 2020].
3. Malaria;Ashley;Lancet,2018
4. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
5. Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective;Rolling;Travel Med Infect Dis,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献